Entry Rationale
The current price of $6.98 slightly exceeds the 20-day high resistance level of $6.92, while the support level is positioned at $3.96. I will monitor whether it successfully breaks through the all-time high and consider entering.
Iovance Biotherapeutics stock hits 52-week high at 6.94 USD
Iovance Biotherapeutics' stock price reached a 52-week high of 6.94 USD.
The current price of $6.98 slightly exceeds the 20-day high resistance level of $6.92, while the support level is positioned at $3.96. I will monitor whether it successfully breaks through the all-time high and consider entering.
The current price of $6.98 is above the resistance level of $6.92, so if it fails to establish a breakthrough and pulls back, we will allow for a decline down to the support level of $3.96 and respond with a stop-loss. Conversely, if the upward trend continues, we will set a profit-taking target around the resistance level of $6.92.
The technical indicators at the entry point show an RSI(14) of 68.6, a positive alignment of moving averages, a trading volume at 0.83 times the 20-day average, and a recent 7-day volatility of +49.5%.
There is a historical precedent showing a price reaction of +12.4% on August 6, 2026.
At the time of entry, the current price of $6.98 was slightly above the resistance level of $6.92, which was the 20-day high, while the support level was at $3.96. A predicted return of 3.5% was set, monitoring whether the stock would successfully break through to a new high. However, the actual result significantly exceeded the prediction, recording a return of 18.8%, resulting in an OVERHIT designation. At that time, the RSI was 68.6, with a positive alignment of moving averages and a strong volatility of +49.5% over the past 7 days. Despite this, trading volume was somewhat limited at 0.83 times the 20-day average, leading to a conservative view on the potential for such strong upward momentum, which contributed to the difference between the prediction and the actual result.
In the upcoming trades, if there is an attempt to reach a new high accompanied by strong volatility while the moving averages are in a positive alignment, I will reflect strategic flexibility in the next trades by keeping the profit-taking target open, even if the trading volume is somewhat lower than the 20-day average, without underestimating the momentum of the trend.